Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crofelemer for Chronic Idiopathic Diarrhea In Non-HIV Patients
NCT03898856Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Apr 2019
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of crofelemer in Chronic Functional Diarrhea, sponsored by UTHealth Houston. Primary endpoint: Number of Participants With a 50 Percent Decrease in Mean Stool Count at 4 weeks. Started Apr 2019; status: completed.
02
Drugs
crofelemer
03
Conditions
Chronic Functional Diarrhea
Beyond the preview
Go deeper on NCT03898856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03898856.